Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Diabetes Research and Clinical Practice|June 1, 1986
Effect of CS-514, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on lipoprotein and apolipoprotein in plasma of hypercholesterolemic diabeticsG Yoshino, T Kazumi, T Kasama, et al.Atherosclerosis|February 1, 1987
Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabeticsT Kasama, G Yoshino, I Iwatani, et al.Journal of Lipid Research|June 1, 1993
Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factorG Yoshino, T Hirano, K Nagata, et al.Diabetes Research and Clinical Practice|January 1, 1989
The role of insulin in triglyceride turnover in ratsM Iwai, G Yoshino, T Kazumi, et al.Atherosclerosis|February 28, 1997
Effect of long-term exogenous hyperinsulinemia and fructose or glucose supplementation on triglyceride turnover in ratsG Yoshino, T Hirano, E Maeda, et al.Metabolism: Clinical and Experimental|January 1, 1993
Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic ratsE Maeda, G Yoshino, M Matsushita, et al.Atherosclerosis|January 27, 1999
Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese menT Kazumi, A Kawaguchi, T Hozumi, et al.Atherosclerosis|October 1, 1988
Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in ratsG Yoshino, T Kazumi, T Kasama, et al.Atherosclerosis|September 1, 1989
Effect of dietary fructose on triglyceride turnover in streptozotocin-diabetic ratsG Yoshino, M Iwai, T Kazumi, et al.Atherosclerosis|January 1, 1989
Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)G Yoshino, T Kazumi, M Iwai, et al.Pageof 8